Australia markets close in 4 hours 52 minutes

Keymed Biosciences Inc. (2162.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
35.600-0.600 (-1.66%)
At close: 04:08PM HKT
Show:
Income statement
Balance sheet
Annual

Cash flow

Currency in CNY. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-359,357
-359,357
-308,115
-3,887,309
-818,583
Depreciation & amortisation
69,161
69,161
36,123
21,019
18,992
Stock-based compensation
40,079
40,079
48,567
116,823
0
Change in working capital
22,425
22,425
-5,670
2,828
-187
Inventory
-11,859
-11,859
-28,102
-9,547
-3,540
Other working capital
-686,230
-686,230
-681,483
-387,495
-139,257
Other non-cash items
-71,516
-71,516
-48,430
3,481,180
702,628
Net cash provided by operating activities
-303,620
-303,620
-401,934
-214,637
-119,361
Cash flows from investing activities
Investments in property, plant and equipment
-382,610
-382,610
-279,549
-172,858
-19,896
Acquisitions, net
-
-
0
-21,000
0
Purchases of investments
-905,237
-905,237
-5,651,169
-2,753,082
-676,965
Sales/maturities of investments
1,605,697
1,605,697
5,076,150
904,113
572,083
Other investing activities
63,560
63,560
155,851
2,906
7,000
Net cash used for investing activities
468,203
468,203
-645,586
-2,035,879
-113,067
Net change in cash
236,714
236,714
-1,055,579
1,387,860
-225,031
Cash at beginning of period
604,070
604,070
1,520,619
199,409
432,608
Cash at end of period
851,029
851,029
604,070
1,520,619
199,409
Free cash flow
Operating cash flow
-303,620
-303,620
-401,934
-214,637
-119,361
Capital expenditure
-382,610
-382,610
-279,549
-172,858
-19,896
Free cash flow
-686,230
-686,230
-681,483
-387,495
-139,257